KR950703566A - 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] - Google Patents

티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]

Info

Publication number
KR950703566A
KR950703566A KR1019950701061A KR19950701061A KR950703566A KR 950703566 A KR950703566 A KR 950703566A KR 1019950701061 A KR1019950701061 A KR 1019950701061A KR 19950701061 A KR19950701061 A KR 19950701061A KR 950703566 A KR950703566 A KR 950703566A
Authority
KR
South Korea
Prior art keywords
thienodiazepine
compound
thienodiazepine compound
medicinal
pharmaceutical
Prior art date
Application number
KR1019950701061A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950703566A publication Critical patent/KR950703566A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
KR1019950701061A 1993-09-16 1995-03-18 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] KR950703566A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001329 WO1994006802A1 (en) 1992-09-18 1993-09-16 Thienodiazepine compound and medicinal use thereof

Publications (1)

Publication Number Publication Date
KR950703566A true KR950703566A (ko) 1995-09-20

Family

ID=14070533

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701061A KR950703566A (ko) 1993-09-16 1995-03-18 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]

Country Status (4)

Country Link
US (1) US5712274A (ko)
EP (1) EP0661284A1 (ko)
KR (1) KR950703566A (ko)
WO (1) WO1994006802A1 (ko)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159344A1 (en) * 1993-03-30 1994-10-13 Minoru Moriwaki Cell adhesion inhibitor and thienotriazolodiazepine compound
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
CA2265645C (en) * 1996-09-13 2007-01-23 Yoshitomi Pharmaceutical Industries Ltd. Thienotriazolodiazepine compounds and pharmaceutical use thereof
FR2791980B1 (fr) * 1999-04-09 2001-07-06 Sod Conseils Rech Applic Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
CA2412776C (en) * 2000-06-16 2011-03-15 Mitsubishi Pharma Corporation Compositions controlling release ph range and/or speed
WO2008067222A1 (en) * 2006-11-28 2008-06-05 Kalypsys, Inc. Heterocyclic modulators of tgr5
CL2008000666A1 (es) * 2007-03-07 2008-06-13 Xenon Pharmaceuticals Inc Compuestos derivados de triciclos sustituidos, inhibidores del transportador de metales divalentes-1; y uso para tratar una enfermedad asociada con un trastorno del hierro.
KR101600634B1 (ko) * 2007-12-28 2016-03-07 미쓰비시 타나베 파마 코퍼레이션 항암제
GB0919432D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Use
US9301962B2 (en) * 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
CN104311562B (zh) * 2010-05-14 2017-07-04 达那-法伯癌症研究所 用于治疗瘤形成、炎性疾病和其他失调的组合物和方法
JP5935030B2 (ja) 2010-05-14 2016-06-15 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド 白血病を治療するための組成物および方法
TWI549955B (zh) * 2010-08-04 2016-09-21 達納 法柏癌症學院有限公司 治療腫瘤形成、發炎疾病及其他病症之組成物及方法
AR084070A1 (es) * 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013033270A2 (en) * 2011-08-29 2013-03-07 Coferon, Inc. Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
DE102011082013A1 (de) 2011-09-01 2013-03-07 Bayer Pharma AG 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
CA2877434A1 (en) 2012-06-25 2014-01-03 Oncoethix Sa Method of treating lymphoma using thienotriazolodiazepine compounds
CA2881996A1 (en) 2012-08-16 2014-02-20 Bayer Pharma Aktiengesellschaft 2,3-benzodiazepines
JP6276277B2 (ja) 2012-09-28 2018-02-07 バイエル ファーマ アクチエンゲゼルシャフト Ｂｅｔタンパク質阻害性の５−アリールトリアゾロアゼピン
WO2014159392A1 (en) * 2013-03-14 2014-10-02 Dana-Farber Cancer Institute, Inc. Bromodomain binding reagents and uses thereof
KR20160034379A (ko) 2013-07-25 2016-03-29 다나-파버 캔서 인스티튜트 인크. 전사 인자의 억제제 및 그의 용도
RU2016122654A (ru) 2013-11-08 2017-12-14 Дана-Фарбер Кэнсер Инститьют, Инк. Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
WO2015081284A1 (en) * 2013-11-26 2015-06-04 Coferon, Inc. Bivalent bromodomain ligands, and methods of using same
EP3099696A4 (en) 2014-01-31 2017-07-05 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
RU2016134947A (ru) 2014-01-31 2018-03-01 Дана-Фарбер Кансер Институт, Инк. Производные диаминопиримидин бензолсульфона и их применение
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
SG11201607108XA (en) 2014-02-28 2016-09-29 Tensha Therapeutics Inc Treatment of conditions associated with hyperinsulinaemia
CN106132968B (zh) * 2014-04-09 2019-04-05 康佳诺医疗科技发展有限公司 一种用于防止或治疗癌症的抑制溴结构域的化合物及含有该化合物的药物组合物
CA2947939A1 (en) 2014-05-28 2015-12-03 Idenix Pharmaceuticals Llc Nucleoside derivatives for the treatment of cancer
DK3157928T3 (da) 2014-06-20 2019-05-20 Constellation Pharmaceuticals Inc Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid
KR20170032473A (ko) 2014-08-08 2017-03-22 다나-파버 캔서 인스티튜트 인크. 디아제판 유도체 및 그의 용도
JP2017525759A (ja) 2014-08-08 2017-09-07 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジヒドロプテリジノン誘導体およびその使用
SG11201703414VA (en) * 2014-10-27 2017-05-30 Tensha Therapeutics Inc Bromodomain inhibitors
KR101675984B1 (ko) 2015-02-23 2016-11-14 한양대학교 에리카산학협력단 티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물
WO2016176335A1 (en) 2015-04-27 2016-11-03 Concert Pharmaceuticals, Inc. Deuterated otx-015
EP3303361A1 (en) 2015-05-27 2018-04-11 Idenix Pharmaceuticals LLC Nucleotides for the treatment of cancer
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
US9599060B2 (en) 2015-07-21 2017-03-21 Ford Global Technologies, Llc Method for operating a fuel injection system
US10337445B2 (en) 2015-07-21 2019-07-02 Ford Global Technologies, Llc Method for operating a dual fuel injection system
SG10202007090UA (en) * 2015-09-11 2020-08-28 Dana Farber Cancer Inst Inc Cyano thienotriazolodiazepines and uses thereof
KR20180051576A (ko) * 2015-09-11 2018-05-16 다나-파버 캔서 인스티튜트 인크. 아세트아미드 티에노트리아졸로디아제핀 및 그의 용도
WO2017091673A2 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibtors and uses thereof
CA3017408A1 (en) 2016-03-15 2017-09-21 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors for the treatment of hematological malignancies
KR102511024B1 (ko) 2016-03-15 2023-03-16 오리존 지노믹스 에스.에이. 고형 종양의 치료에 사용하기 위한 lsd1 억제제의 조합물
WO2017172914A1 (en) 2016-03-30 2017-10-05 Wisconsin Alumni Research Foundation Methods and compositions for modulating frataxin expression
WO2018091542A1 (en) 2016-11-21 2018-05-24 Idenix Pharmaceuticals Llc Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
JP2020502148A (ja) 2016-12-16 2020-01-23 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ジアゼピン誘導体の製造のための方法
WO2018183679A1 (en) 2017-03-29 2018-10-04 Wisconsin Alumni Research Foundation Methods and compositions for modulating gene expression
CA3076759A1 (en) * 2017-09-22 2019-03-28 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Thienodiazepine derivatives and application thereof
AU2019284971A1 (en) 2018-06-13 2020-12-03 Worg Pharmaceuticals (Zhejiang) Co., Ltd. Preparation of condensed triazepine derivatives and their use as BET inhibitors
US20220177490A1 (en) * 2019-03-07 2022-06-09 Medshine Discovery Inc. Compounds having both effects of bet bromodomain protein inhibition and pd-l1 gene regulation
EP3943498A4 (en) * 2019-03-22 2023-01-04 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. BRD4 INHIBITOR COMPOUND IN SOLID FORM AND PROCESSES FOR THE PREPARATION AND USE THEREOF
KR20220139912A (ko) * 2020-02-06 2022-10-17 미쓰비시 타나베 파마 코퍼레이션 Brd4 단백질 분해 유도 작용을 갖는 술폰아미드 또는 술핀아미드 화합물 및 그 의약으로서의 용도
WO2022048685A1 (zh) * 2020-09-07 2022-03-10 南京明德新药研发有限公司 苯并四氢呋喃肟类化合物的晶型及其制备方法
WO2023113457A1 (ko) * 2021-12-14 2023-06-22 (주)프레이저테라퓨틱스 폴리유비퀴틴화에 의한 표적 단백질 또는 폴리펩티드의 분해용 신규 화합물
WO2022221786A2 (en) * 2022-06-22 2022-10-20 Plexium, Inc. Compounds and pharmaceutical compositions that modulate brd4

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5745755B2 (ko) * 1974-01-08 1982-09-29
JPS5747916B2 (ko) * 1974-05-13 1982-10-13
MC1999A1 (fr) * 1987-12-18 1990-01-26 Hoffmann La Roche Composes tricycliques
WO1989005812A1 (en) * 1987-12-22 1989-06-29 Yoshitomi Pharmaceutical Industries, Ltd. Thienodiazepine compounds and their medicinal use
EP0368175A1 (de) * 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
EP0387613A1 (de) * 1989-03-03 1990-09-19 Boehringer Ingelheim Kg Neue Thienodiazepine
JP2953045B2 (ja) * 1989-12-01 1999-09-27 吉富製薬株式会社 チエノジアゼピン化合物
JPH04297479A (ja) * 1991-02-20 1992-10-21 Yamanouchi Pharmaceut Co Ltd 新規チェノジアゼピン誘導体
KR100255493B1 (ko) * 1991-10-11 2000-08-01 가마쿠라 아키오 골조송증 치료제
GB9218412D0 (en) * 1992-08-28 1992-10-14 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
US5712274A (en) 1998-01-27
EP0661284A1 (en) 1995-07-05
WO1994006802A1 (en) 1994-03-31
EP0661284A4 (en) 1995-05-23

Similar Documents

Publication Publication Date Title
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
BR1100329A (pt) Composto e formulação farmacêutica
BR1100824A (pt) Composto e composição farmacêutica
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
DE69525148T2 (de) Pharmazeutische formulierung
NO954146D0 (no) Belagte farmasöytiske preparater
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
KR960700239A (ko) 크로만 유도체 및 그의 제약학적 용도(chroman derivative and medicinal use thereof)
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
BR9408457A (pt) Preparação farmacêutica percutânia
NO930677L (no) Farmasoeytiske forbindelser
DE69320242D1 (de) Medizinische Selbstklebefolie und Arzneimittelzubereitung
BR9200058A (pt) Composto e composicao farmaceutica
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
DE59407193D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE4294862T1 (de) Pharmazeutische Komposition
BR9509688A (pt) Composto e composição farmacêutica
NO931008D0 (no) Farmasoeytiske forbindelser
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69323568T2 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
DE59410107D1 (de) Chinoxaline und arzneimittel daraus

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application